Clinical Trial Update: Hydrocortisone in Hormone Replacement Therapy for Large Pituitary Neuroendocrine Tumors [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update on hydrocortisone used in hormone replacement therapy for large pituitary neuroendocrine tumors, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pituitary Adenoma
• Pituitary Neuroendocrine Tumor

Drugs mentioned

• HYDROCORTISONE (HYDROCORTISONE)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Pituitary Adenoma, Pituitary Neuroendocrine Tumor | Phase 4 | Status: RECRUITING